Heerma Peter

Insider CIK 1789617 · TVTX EVP, CHIEF COMMERCIAL OFFICER

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
TVTX Travere Therapeutics, Inc.	M Exercise deriv	2026-09-17	2026-09-17	8,282	—	$0	44,837	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2026-09-17	2026-09-17	8,282	$65.07	$538.9K	117,066	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise	2026-09-17	2026-09-17	8,282	$22.40	$185.5K	125,348	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise deriv	2026-09-17	2026-09-17	8,282	—	$0	44,837	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2026-09-17	2026-09-17	8,282	$65.07	$538.9K	117,066	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise	2026-09-17	2026-09-17	8,282	$22.40	$185.5K	125,348	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise deriv	2026-09-16	2026-09-17	100,000	—	$0	0	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise deriv	2026-09-16	2026-09-17	55,000	—	$0	0	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise deriv	2026-09-16	2026-09-17	17,717	—	$0	500	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise	2026-09-16	2026-09-17	100,000	$11.25	$1.13M	217,066	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2026-09-16	2026-09-17	79,113	$63.65	$5.04M	117,066	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2026-09-16	2026-09-17	93,604	$63.25	$5.92M	196,179	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise	2026-09-16	2026-09-17	17,717	$26.88	$476.2K	289,783	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise	2026-09-16	2026-09-17	55,000	$15.46	$850.3K	272,066	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise deriv	2026-09-16	2026-09-17	17,717	—	$0	500	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise deriv	2026-09-16	2026-09-17	55,000	—	$0	0	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise deriv	2026-09-16	2026-09-17	100,000	—	$0	0	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2026-09-16	2026-09-17	79,113	$63.65	$5.04M	117,066	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2026-09-16	2026-09-17	93,604	$63.25	$5.92M	196,179	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise	2026-09-16	2026-09-17	17,717	$26.88	$476.2K	289,783	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise	2026-09-16	2026-09-17	55,000	$15.46	$850.3K	272,066	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise	2026-09-16	2026-09-17	100,000	$11.25	$1.13M	217,066	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise deriv	2026-09-15	2026-09-17	36,526	—	$0	28,474	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise deriv	2026-09-15	2026-09-17	1,381	—	$0	53,119	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise deriv	2026-09-15	2026-09-17	39,283	—	$0	18,217	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise	2026-09-15	2026-09-17	39,283	$26.88	$1.06M	181,349	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise	2026-09-15	2026-09-17	1,381	$22.40	$30.9K	182,730	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise	2026-09-15	2026-09-17	36,526	$8.93	$326.2K	219,256	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2026-09-15	2026-09-17	71,938	$62.05	$4.46M	147,318	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2026-09-15	2026-09-17	27,421	$62.59	$1.72M	119,897	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2026-09-15	2026-09-17	1,400	$63.65	$89.1K	118,497	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2026-09-15	2026-09-17	1,431	$65.31	$93.5K	117,066	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise deriv	2026-09-15	2026-09-17	36,526	—	$0	28,474	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise deriv	2026-09-15	2026-09-17	1,381	—	$0	53,119	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise deriv	2026-09-15	2026-09-17	39,283	—	$0	18,217	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2026-09-15	2026-09-17	1,431	$65.31	$93.5K	117,066	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2026-09-15	2026-09-17	1,400	$63.65	$89.1K	118,497	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2026-09-15	2026-09-17	27,421	$62.59	$1.72M	119,897	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2026-09-15	2026-09-17	71,938	$62.05	$4.46M	147,318	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise	2026-09-15	2026-09-17	36,526	$8.93	$326.2K	219,256	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise	2026-09-15	2026-09-17	1,381	$22.40	$30.9K	182,730	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise	2026-09-15	2026-09-17	39,283	$26.88	$1.06M	181,349	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2026-05-05	2026-05-06	2,174	$46.65	$101.4K	140,684	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise deriv	2026-05-04	2026-05-06	4,250	—	$0	4,250	SEC↗
TVTX Travere Therapeutics, Inc.	A Award deriv	2026-05-04	2026-05-06	8,500	—	$0	8,500	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise	2026-05-04	2026-05-06	4,250	—	$0	142,858	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2026-04-14	2026-04-15	7,215	$41.93	$302.5K	138,608	SEC↗
TVTX Travere Therapeutics, Inc.	A Award	2026-04-13	2026-04-15	14,000	—	$0	145,823	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2026-02-03	2026-02-03	7,310	$32.12	$234.8K	131,823	SEC↗
TVTX Travere Therapeutics, Inc.	A Award deriv	2026-01-31	2026-02-03	69,640	—	$0	69,640	SEC↗
TVTX Travere Therapeutics, Inc.	A Award	2026-01-31	2026-02-03	26,120	—	$0	139,133	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2025-12-24	2025-12-29	4,980	$40.00	$199.2K	113,013	SEC↗
TVTX Travere Therapeutics, Inc.	G Gift	2025-11-03	2025-11-04	1,078	—	$0	117,993	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2025-10-31	2025-11-04	5,591	$35.00	$195.7K	119,071	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2025-10-28	2025-10-30	2,662	$30.00	$79.9K	124,662	SEC↗
TVTX Travere Therapeutics, Inc.	G Gift	2025-09-23	2025-09-24	891	—	$0	127,324	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2025-05-05	2025-05-05	1,771	$21.05	$37.3K	128,215	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise deriv	2025-05-02	2025-05-05	4,920	—	$0	4,920	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise	2025-05-02	2025-05-05	4,920	—	$0	129,986	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2025-02-12	2025-02-12	2,568	$23.53	$60.4K	125,066	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2025-02-11	2025-02-12	3,074	$25.00	$76.8K	127,634	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise deriv	2025-02-10	2025-02-12	8,000	—	$0	0	SEC↗
TVTX Travere Therapeutics, Inc.	M Exercise	2025-02-10	2025-02-12	8,000	—	$0	130,708	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2025-02-03	2025-02-04	5,166	$20.12	$103.9K	122,708	SEC↗
TVTX Travere Therapeutics, Inc.	A Award deriv	2025-01-31	2025-02-04	58,000	—	$0	58,000	SEC↗
TVTX Travere Therapeutics, Inc.	A Award	2025-01-31	2025-02-04	21,500	—	$0	127,874	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2025-01-22	2025-01-23	1,584	$18.94	$30.0K	106,374	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2024-09-09	2024-09-09	2,191	$11.52	$25.2K	107,958	SEC↗
TVTX Travere Therapeutics, Inc.	A Award	2024-09-05	2024-09-09	6,750	—	$0	110,149	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2024-02-01	2024-02-02	4,195	$8.53	$35.8K	99,503	SEC↗
TVTX Travere Therapeutics, Inc.	A Award deriv	2024-01-31	2024-02-02	65,000	—	$0	65,000	SEC↗
TVTX Travere Therapeutics, Inc.	A Award	2024-01-31	2024-02-02	25,000	—	$0	103,698	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2024-01-23	2024-01-25	1,559	$9.07	$14.1K	78,698	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2023-10-03	2023-10-04	3,091	$8.25	$25.5K	80,257	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2023-02-01	2023-02-02	1,779	$21.75	$38.7K	82,069	SEC↗
TVTX Travere Therapeutics, Inc.	A Award deriv	2023-01-31	2023-02-02	6,750	—	$0	6,750	SEC↗
TVTX Travere Therapeutics, Inc.	A Award deriv	2023-01-31	2023-02-02	54,500	—	$0	54,500	SEC↗
TVTX Travere Therapeutics, Inc.	A Award	2023-01-31	2023-02-02	20,250	—	$0	83,848	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2023-01-24	2023-01-26	1,550	$21.90	$33.9K	63,598	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2022-10-04	2022-10-06	3,042	$25.68	$78.1K	65,148	SEC↗
TVTX Travere Therapeutics, Inc.	A Award deriv	2022-01-31	2022-02-02	8,000	—	$0	8,000	SEC↗
TVTX Travere Therapeutics, Inc.	A Award deriv	2022-01-31	2022-02-02	9,840	—	$0	9,840	SEC↗
TVTX Travere Therapeutics, Inc.	A Award deriv	2022-01-31	2022-02-02	39,360	—	$0	39,360	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2022-01-31	2022-02-02	1,125	$27.40	$30.8K	67,297	SEC↗
TVTX Travere Therapeutics, Inc.	A Award	2022-01-31	2022-02-02	9,840	—	$0	68,422	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2022-01-24	2022-01-26	1,875	$24.98	$46.8K	58,582	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2021-10-04	2021-10-05	3,058	$24.77	$75.7K	60,457	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2021-08-17	2021-08-17	1,407	$17.12	$24.1K	63,515	SEC↗
TVTX Travere Therapeutics, Inc.	A Award	2021-08-13	2021-08-17	4,500	—	$0	64,922	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2021-02-08	2021-02-09	1,125	$31.58	$35.5K	59,344	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2021-02-05	2021-02-09	1,125	$31.41	$35.3K	60,469	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2021-02-03	2021-02-03	563	$28.91	$16.3K	57,094	SEC↗
TVTX Travere Therapeutics, Inc.	A Award	2021-02-03	2021-02-05	4,500	—	$0	61,594	SEC↗
TVTX Travere Therapeutics, Inc.	S Sale	2021-02-02	2021-02-03	563	$30.75	$17.3K	57,657	SEC↗
TVTX Travere Therapeutics, Inc.	A Award deriv	2021-01-21	2021-01-25	57,500	—	$0	57,500	SEC↗
TVTX Travere Therapeutics, Inc.	A Award	2021-01-21	2021-01-25	15,000	—	$0	58,220	SEC↗
RTRX Retrophin, Inc.	S Sale	2020-10-05	2020-10-05	2,188	$19.35	$42.3K	42,329	SEC↗
RTRX Retrophin, Inc.	S Sale	2020-10-02	2020-10-05	2,188	$18.90	$41.4K	44,517	SEC↗
RTRX Retrophin, Inc.	A Award deriv	2020-01-31	2020-01-31	9,000	—	$0	9,000	SEC↗
RTRX Retrophin, Inc.	A Award deriv	2020-01-31	2020-01-31	55,000	—	$0	55,000	SEC↗
RTRX Retrophin, Inc.	A Award	2020-01-31	2020-01-31	9,000	—	$0	44,000	SEC↗
RTRX Retrophin, Inc.	A Award deriv	2019-10-01	2019-10-02	100,000	—	$0	100,000	SEC↗
RTRX Retrophin, Inc.	A Award	2019-10-01	2019-10-02	35,000	—	$0	35,000	SEC↗